Informed Girl
Informed SkinKybella

Biostimulators

Kybella

Deoxycholic acid (ATX-101)

FDA-approved injectable fat dissolution for submental fullness

Volume LossSagging Jowls
In plain English

A synthetic version of a bile acid is injected into the fat under your chin to permanently destroy those fat cells. FDA-approved, permanent fat reduction -- but each session causes significant swelling and bruising for 1-2 weeks, and nerve injury affecting the smile was documented in 4.3% of Phase 3 trial patients (though all resolved). Requires 2-6 sessions. It works, but the recovery is real and significant.

Safe for skin types
Safe forAll Fitzpatrick types I–VI
Use cautionNone specific to skin tone
Avoid ifNone related to Fitzpatrick type

Deoxycholic acid targets adipocyte cell membranes, not melanin. Fat cell destruction and the subsequent inflammatory response are not affected by skin tone or Fitzpatrick type. Efficacy and risk profile are equivalent across all skin tones.

Common misconceptions
Myth

Kybella results in gradual subtle reduction.

Reality

Post-injection swelling is severe and the clinical process involves a significant visible inflammatory response. Patients should plan around 1-2 weeks of visible recovery per session.

Myth

Any fat-dissolving injection is as safe as Kybella.

Reality

Only Kybella and Belkyra have FDA-approved safety and efficacy data at a defined concentration and injection protocol. Compounded or unlicensed deoxycholic acid alternatives have documented cases of skin necrosis and are not equivalent.

Quick Facts
Duration20-30 min; 2-6 sessions needed; permanent fat reduction
Studies150+
FDA StatusFDA-approved (2015) for submental fat reduction
Price$1,200-$3,000 per session

Should You Try This?

15105OUT OF 10

Probably wait for more data

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com

The Weekly Briefing

Stay informed

Every paper is individually reviewed and scored for study design, blinding, and funding independence. Educational content, not medical advice.

Subscribe for updates about the latest research. No spam.